Beta Drugs Limited (NSE:BETA)
India · Delayed Price · Currency is INR 1,341.80
+19.50 (1.47%)
At close: May 11, 2026
Beta Drugs Market Cap
Beta Drugs has a market cap or net worth of 13.35 billion as of May 11, 2026. Its market cap has decreased by -29.00% in one year.
Market Cap
13.35B
Enterprise Value
13.58B
Revenue
3.85B
Ranking
n/a
PE Ratio
33.44
Stock Price
1,341.80
Market Cap Chart
Since October 25, 2017, Beta Drugs's market cap has increased from 915.98M to 13.35B, an increase of 1,357.24%. That is a compound annual growth rate of 36.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 13.35B | -14.64% |
| Dec 31, 2025 | 15.64B | -19.04% |
| Dec 31, 2024 | 19.31B | 36.67% |
| Dec 29, 2023 | 14.13B | 107.04% |
| Dec 30, 2022 | 6.83B | 10.89% |
| Dec 31, 2021 | 6.16B | 497.76% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Oct 25, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 50.11B |
| RPG Life Sciences | 40.74B |
| Orchid Pharma | 35.68B |
| Solara Active Pharma Sciences | 25.31B |
| Indoco Remedies | 21.04B |
| Windlas Biotech | 17.37B |
| Jagsonpal Pharmaceuticals | 14.59B |
| Sakar Healthcare | 12.14B |